ID ENLYS_LAMBD Reviewed; 158 AA. AC P03706; DT 21-JUL-1986, integrated into UniProtKB/Swiss-Prot. DT 21-JUL-1986, sequence version 1. DT 08-NOV-2023, entry version 128. DE RecName: Full=Endolysin {ECO:0000255|HAMAP-Rule:MF_04109, ECO:0000303|Ref.2}; DE EC=4.2.2.n2 {ECO:0000255|HAMAP-Rule:MF_04109, ECO:0000269|PubMed:10556513, ECO:0000269|PubMed:6448076}; DE AltName: Full=Lysis protein {ECO:0000255|HAMAP-Rule:MF_04109}; DE AltName: Full=Lysozyme {ECO:0000255|HAMAP-Rule:MF_04109, ECO:0000303|PubMed:10556513, ECO:0000303|PubMed:4889461}; DE AltName: Full=Transglycosylase {ECO:0000255|HAMAP-Rule:MF_04109, ECO:0000303|PubMed:6460914}; GN Name=R; OS Escherichia phage lambda (Bacteriophage lambda). OC Viruses; Duplodnaviria; Heunggongvirae; Uroviricota; Caudoviricetes; OC Lambdavirus; Lambdavirus lambda. OX NCBI_TaxID=2681611; OH NCBI_TaxID=562; Escherichia coli. RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=6221115; DOI=10.1016/0022-2836(82)90546-0; RA Sanger F., Coulson A.R., Hong G.F., Hill D.F., Petersen G.B.; RT "Nucleotide sequence of bacteriophage lambda DNA."; RL J. Mol. Biol. 162:729-773(1982). RN [2] RP PROTEIN SEQUENCE. RA Imada M., Tsugita A.; RT "Amino-acid sequence of lambda phage endolysin."; RL Nature New Biol. 233:230-231(1971). RN [3] RP CHARACTERIZATION, AND SUBUNIT. RX PubMed=4889461; DOI=10.1016/s0021-9258(18)94354-1; RA Black L.W., Hogness D.S.; RT "The lysozyme of bacteriophage lambda. I. Purification and molecular RT weight."; RL J. Biol. Chem. 244:1968-1975(1969). RN [4] RP CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=6448076; DOI=10.1016/0005-2744(80)90515-x; RA Bienkowska-Szewczyk K., Taylor A.; RT "Murein transglycosylase from phage lambda lysate. Purification and RT properties."; RL Biochim. Biophys. Acta 615:489-496(1980). RN [5] RP IDENTIFICATION. RX PubMed=6460914; DOI=10.1007/bf00271205; RA Bienkowska-Szewczyk K., Lipinska B., Taylor A.; RT "The R gene product of bacteriophage lambda is the murein RT transglycosylase."; RL Mol. Gen. Genet. 184:111-114(1981). RN [6] RP MUTAGENESIS OF HIS-31; HIS-48 AND HIS-137, AND CATALYTIC ACTIVITY. RX PubMed=10556513; DOI=10.1016/s0014-5793(99)01395-2; RA Evrard C., Fastrez J., Soumillion P.; RT "Histidine modification and mutagenesis point to the involvement of a large RT conformational change in the mechanism of action of phage lambda RT lysozyme."; RL FEBS Lett. 460:442-446(1999). RN [7] RP REVIEW. RX PubMed=24113139; DOI=10.1016/j.mib.2013.08.008; RA Young R.; RT "Phage lysis: do we have the hole story yet?"; RL Curr. Opin. Microbiol. 16:790-797(2013). RN [8] RP X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS), AND ACTIVE SITE. RX PubMed=9514719; DOI=10.1006/jmbi.1997.1499; RA Evrard C., Fastrez J., Declercq J.-P.; RT "Crystal structure of the lysozyme from bacteriophage lambda and its RT relationship with V and C-type lysozymes."; RL J. Mol. Biol. 276:151-164(1998). RN [9] RP STRUCTURE BY NMR. RX PubMed=20300891; DOI=10.1007/s12104-010-9219-8; RA Di Paolo A., Duval V., Matagne A., Redfield C.; RT "Backbone 1H, 13C, and 15N resonance assignments for lysozyme from RT bacteriophage lambda."; RL Biomol. NMR. Assign. 4:111-114(2010). CC -!- FUNCTION: Endolysin with transglycosylase activity that degrades host CC peptidoglycans and participates with the holin and spanin proteins in CC the sequential events which lead to the programmed host cell lysis CC releasing the mature viral particles. Once the holin has permeabilized CC the host cell membrane, the endolysin can reach the periplasm and break CC down the peptidoglycan layer. {ECO:0000255|HAMAP-Rule:MF_04109, CC ECO:0000305|PubMed:10556513, ECO:0000305|PubMed:24113139}. CC -!- CATALYTIC ACTIVITY: CC Reaction=Endolytic cleavage of the (1->4)-beta-glycosidic linkage CC between N-acetylmuramic acid (MurNAc) and N-acetylglucosamine CC (GlcNAc) residues in peptidoglycan with concomitant formation of a CC 1,6-anhydrobond in the MurNAc residue.; EC=4.2.2.n2; CC Evidence={ECO:0000255|HAMAP-Rule:MF_04109, CC ECO:0000269|PubMed:10556513, ECO:0000269|PubMed:6448076}; CC -!- ACTIVITY REGULATION: Inactivated by zinc. {ECO:0000269|PubMed:6448076}. CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC pH dependence: CC Optimum pH is 6.6. {ECO:0000269|PubMed:6448076}; CC -!- SUBUNIT: Monomer. {ECO:0000255|HAMAP-Rule:MF_04109, CC ECO:0000269|PubMed:4889461}. CC -!- SUBCELLULAR LOCATION: Host cytoplasm {ECO:0000255|HAMAP-Rule:MF_04109}. CC Note=The endolysin is cytoplasmic, but can reach the periplasmic space CC with the help of the holins which disrupt the host cell membrane. CC {ECO:0000255|HAMAP-Rule:MF_04109, ECO:0000305|PubMed:24113139}. CC -!- SIMILARITY: Belongs to the glycosyl hydrolase 24 family. CC {ECO:0000255|HAMAP-Rule:MF_04109}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; J02459; AAA96598.1; -; Genomic_DNA. DR PIR; B04333; EYBPL. DR RefSeq; NP_040645.1; NC_001416.1. DR PDB; 1AM7; X-ray; 2.30 A; A/B/C=1-158. DR PDB; 1D9U; X-ray; 2.60 A; A/B=1-154. DR PDB; 3D3D; X-ray; 2.60 A; A/B=1-154. DR PDBsum; 1AM7; -. DR PDBsum; 1D9U; -. DR PDBsum; 3D3D; -. DR BMRB; P03706; -. DR SMR; P03706; -. DR IntAct; P03706; 1. DR DrugBank; DB04206; 7-Aza-L-tryptophan. DR CAZy; GH104; Glycoside Hydrolase Family 104. DR GeneID; 2703480; -. DR KEGG; vg:2703480; -. DR OrthoDB; 10116at10239; -. DR EvolutionaryTrace; P03706; -. DR Proteomes; UP000001711; Genome. DR GO; GO:0030430; C:host cell cytoplasm; IEA:UniProtKB-SubCell. DR GO; GO:0003796; F:lysozyme activity; IDA:UniProtKB. DR GO; GO:0008933; F:lytic transglycosylase activity; IDA:UniProtKB. DR GO; GO:0016998; P:cell wall macromolecule catabolic process; IEA:InterPro. DR GO; GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW. DR GO; GO:0009253; P:peptidoglycan catabolic process; IEA:UniProtKB-UniRule. DR GO; GO:0044659; P:viral release from host cell by cytolysis; IDA:UniProtKB. DR CDD; cd00736; lambda_lys-like; 1. DR Gene3D; 1.10.530.10; -; 1. DR HAMAP; MF_04109; ENDOLYSIN_LAMBDA; 1. DR InterPro; IPR034691; Endolysin_lambda_type. DR InterPro; IPR002196; Glyco_hydro_24. DR InterPro; IPR023346; Lysozyme-like_dom_sf. DR Pfam; PF00959; Phage_lysozyme; 1. DR SUPFAM; SSF53955; Lysozyme-like; 1. PE 1: Evidence at protein level; KW 3D-structure; Antimicrobial; Bacteriolytic enzyme; Cytolysis; KW Direct protein sequencing; Host cell lysis by virus; Host cytoplasm; Lyase; KW Reference proteome; Viral release from host cell. FT CHAIN 1..158 FT /note="Endolysin" FT /id="PRO_0000218108" FT ACT_SITE 19 FT /evidence="ECO:0000255|HAMAP-Rule:MF_04109, FT ECO:0000269|PubMed:9514719" FT MUTAGEN 31 FT /note="H->D: No effect on lytic activity." FT /evidence="ECO:0000269|PubMed:10556513" FT MUTAGEN 31 FT /note="H->N: No effect on lytic activity; when associated FT with N-137." FT /evidence="ECO:0000269|PubMed:10556513" FT MUTAGEN 48 FT /note="H->N: 97% loss of lytic activity." FT /evidence="ECO:0000269|PubMed:10556513" FT MUTAGEN 137 FT /note="H->N: No effect on lytic activity; when associated FT with N-31." FT /evidence="ECO:0000269|PubMed:10556513" FT CONFLICT 74 FT /note="Missing (in Ref. 2; AA sequence)" FT /evidence="ECO:0000305" FT HELIX 6..16 FT /evidence="ECO:0007829|PDB:1AM7" FT STRAND 20..26 FT /evidence="ECO:0007829|PDB:1AM7" FT TURN 31..34 FT /evidence="ECO:0007829|PDB:1AM7" FT STRAND 53..56 FT /evidence="ECO:0007829|PDB:1AM7" FT STRAND 59..61 FT /evidence="ECO:0007829|PDB:1AM7" FT TURN 65..68 FT /evidence="ECO:0007829|PDB:1AM7" FT HELIX 76..81 FT /evidence="ECO:0007829|PDB:1AM7" FT HELIX 88..101 FT /evidence="ECO:0007829|PDB:1AM7" FT HELIX 105..110 FT /evidence="ECO:0007829|PDB:1AM7" FT HELIX 113..120 FT /evidence="ECO:0007829|PDB:1AM7" FT TURN 121..123 FT /evidence="ECO:0007829|PDB:1AM7" FT STRAND 132..134 FT /evidence="ECO:0007829|PDB:1D9U" FT HELIX 135..148 FT /evidence="ECO:0007829|PDB:1AM7" SQ SEQUENCE 158 AA; 17825 MW; 94F8E9A512EAA03E CRC64; MVEINNQRKA FLDMLAWSEG TDNGRQKTRN HGYDVIVGGE LFTDYSDHPR KLVTLNPKLK STGAGRYQLL SRWWDAYRKQ LGLKDFSPKS QDAVALQQIK ERGALPMIDR GDIRQAIDRC SNIWASLPGA GYGQFEHKAD SLIAKFKEAG GTVREIDV //